Anectine

   
Google
 
Web NewDrugInformation.com

Anectine


Drug - Anectine
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Succinylcholine Chloride
Multiple ingredients are in alphabetical order.

Strength - 20MG/ML
The potency of the active ingredient(s), Succinylcholine Chloride. May repeat for multiple part products.

Applicant - SABEX 2002
The firm name holding legal responsibility for Anectine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 008453
The FDA assigned number to Anectine. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Anectine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Anectine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Anectine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Anectine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sabex 2002 Inc
The full name of the firm holding legal responsibility for the new application of Anectine.

Anectine